Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the ...

Boehringer Ingelheim and South Korean biotech Bridge ... Bridge is also resident at Johnson & Johnson’s JLABS facility in Shanghai.

Denmark's Zealand Pharma and German partner Boehringer Ingelheim have won the U.S. Food and Drug Administration's ...

CHEN MENGZE/FOR CHINA DAILY SHANGHAI -- With the seventh China ... president and CEO of Boehringer-Ingelheim Greater China said. Mohammed Tawil noted the example of Spevigo, a therapy for treating ...

For years, there have been bottlenecks in the medicine supply in Europe and these have worsened in recent months in Germany.

SN discloses stock options for Brainomix and was a speaker with Bayer, Boehringer Ingelheim ... from Covidien Healthcare International Trading (Shanghai), Johnson & Johnson MedTech, Genesis ...

By Noah Weiland and Rebecca Robbins Hikma said it had reduced the cash portion of the offer as Boehringer Ingelheim’s generic drugs business in the U.S. had lower-than-expected sales.

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare servic ...

She's currently the Chief Medical Officer and Head of Medicine at Boehringer Ingelheim. Well, Dr. Hinsch Gylvin. Thanks for joining me today. That really has changed. So first and foremost ...

Hosted by Boehringer Ingelheim, the ‘CRM Summit’, an expert engagement forum, and the ‘IMETA CRM Discussions for EXperts (MEDEX CRM)’, a scientific expert meeting, brought together healthcare ...